Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-02-29 to 2024-03-15
Current total value of award: $845.28
Description: 8510479175!HEPATITIS A VIRUS V